Kinoshita and colleagues found putative pathological PKD1 and PKD2 mutations in 89% (90 of 101) of Japanese ADPKD patients with a long-range PCR and next-generation sequencing platform [33]. This evidence concerns the gene PKD2 and autosomal dominant polycystic kidney disease.